Susquehanna International Group
IART icon

Susquehanna International Group’s Integra LifeSciences IART Stock Holding History

Susquehanna International Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,100
Closed -$202K – 12637
2024
Q3 		$202K Sell
11,100
-2,300
-17% -$53.3K ﹤0.01% 10457
2024
Q2 		$390K Buy
13,400
+6,700
+100% +$199K ﹤0.01% 8859
2024
Q1 		$238K Buy
+6,700
New +$268K ﹤0.01% 10228
2023
Q2 		– Sell
-14,100
Closed -$809K – 12532
2023
Q1 		$809K Sell
14,100
-22,400
-61% -$1.26M ﹤0.01% 7380
2022
Q4 		$2.05M Buy
36,500
+27,400
+301% +$1.39M ﹤0.01% 4667
2022
Q3 		$385K Sell
9,100
-16,400
-64% -$840K ﹤0.01% 9157
2022
Q2 		$1.38M Buy
+25,500
New +$1.53M ﹤0.01% 5752
2022
Q1 		– Sell
-22,400
Closed -$1.5M – 13431
2021
Q4 		$1.5M Buy
+22,400
New +$1.52M ﹤0.01% 6209
2021
Q2 		– Sell
-6,400
Closed -$442K – 12859
2021
Q1 		$442K Sell
6,400
-13,300
-68% -$901K ﹤0.01% 9760
2020
Q4 		$1.28M Buy
+19,700
New +$1.06M ﹤0.01% 6101
2020
Q3 		– Sell
-10,600
Closed -$498K – 10793
2020
Q2 		$498K Buy
+10,600
New +$521K ﹤0.01% 7364
2019
Q2 		– Sell
-22,000
Closed -$1.23M – 10481
2019
Q1 		$1.23M Buy
+22,000
New +$1.12M ﹤0.01% 4624
2017
Q2 		– Sell
-45,600
Closed -$1.92M – 9448
2017
Q1 		$1.92M Buy
45,600
+11,000
+32% +$470K ﹤0.01% 3810
2016
Q4 		$1.48M Buy
+34,600
New +$1.41M ﹤0.01% 4689
2014
Q4 		– Sell
-13,456
Closed -$273K – 9817
2014
Q3 		$273K Sell
13,456
-16,146
-55% -$321K ﹤0.01% 8161
2014
Q2 		$569K Buy
+29,602
New +$552K ﹤0.01% 7220
2014
Q1 		– Sell
-12,966
Closed -$253K – 9115
2013
Q4 		$253K Buy
+12,966
New +$238K ﹤0.01% 7859

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group's IART Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Integra LifeSciences (IART) in Q1 2026: 25,745 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #11332 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in IART as recently as Q3 2025.

Susquehanna International Group first reported a position in IART in Q2 2013 and has held it in 39 quarters since. The position peaked at $12.2M in Q2 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Susquehanna International Group held 25,745 shares of Integra LifeSciences worth $243K as of Q1 2026.
  • Integra LifeSciences was a new Susquehanna International Group position in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11332 holding.
  • Susquehanna International Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 39 quarters since.
  • Susquehanna International Group's Integra LifeSciences position peaked at $12.2M in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.